Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kiehn

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Trends in Cardiovascular Medicine|April 3, 2001
Regulation of the cardiac repolarizing HERG potassium channel by protein kinase AJ Kiehn
Cancer|July 15, 1982
Combined histologic grading of prostatic carcinomaA Böcking, J Kiehn, M Heinzel-Wach
Current Pharmaceutical Design|June 22, 2006
The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applicationsD Thomas, C A Karle, J Kiehn
Journal of Cardiovascular Pharmacology|October 1, 1994
Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytesJ Kiehn, P Villena, T Beyer, et al.
The American Journal of Physiology|July 17, 1999
Pathways of HERG inactivationJ Kiehn, A E Lacerda, A M Brown
Circulation|November 15, 1996
Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilideJ Kiehn, A E Lacerda, B Wible, et al.
Molecular Pharmacology|August 1, 1996
Mapping the block of a cloned human inward rectifier potassium channel by dofetilideJ Kiehn, B Wible, A E Lacerda, et al.
Circulation Research|March 5, 1998
Molecular determinants of dofetilide block of HERG K+ channelsE Ficker, W Jarolimek, J Kiehn, et al.
Circulation Research|December 1, 1995
Cloned human inward rectifier K+ channel as a target for class III methanesulfonanilidesJ Kiehn, B Wible, E Ficker, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 20, 1999
Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channelsJ Kiehn, D Thomas, C A Karle, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Trends in Cardiovascular Medicine|April 3, 2001
Regulation of the cardiac repolarizing HERG potassium channel by protein kinase AJ Kiehn
Cancer|July 15, 1982
Combined histologic grading of prostatic carcinomaA Böcking, J Kiehn, M Heinzel-Wach
Current Pharmaceutical Design|June 22, 2006
The cardiac hERG/IKr potassium channel as pharmacological target: structure, function, regulation, and clinical applicationsD Thomas, C A Karle, J Kiehn
Journal of Cardiovascular Pharmacology|October 1, 1994
Differential effects of the new class III agent dofetilide on potassium currents in guinea pig cardiomyocytesJ Kiehn, P Villena, T Beyer, et al.
The American Journal of Physiology|July 17, 1999
Pathways of HERG inactivationJ Kiehn, A E Lacerda, A M Brown
Circulation|November 15, 1996
Molecular physiology and pharmacology of HERG. Single-channel currents and block by dofetilideJ Kiehn, A E Lacerda, B Wible, et al.
Molecular Pharmacology|August 1, 1996
Mapping the block of a cloned human inward rectifier potassium channel by dofetilideJ Kiehn, B Wible, A E Lacerda, et al.
Circulation Research|March 5, 1998
Molecular determinants of dofetilide block of HERG K+ channelsE Ficker, W Jarolimek, J Kiehn, et al.
Circulation Research|December 1, 1995
Cloned human inward rectifier K+ channel as a target for class III methanesulfonanilidesJ Kiehn, B Wible, E Ficker, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|April 20, 1999
Inhibitory effects of the class III antiarrhythmic drug amiodarone on cloned HERG potassium channelsJ Kiehn, D Thomas, C A Karle, et al.
Pageof 3